This Mid Cap Pharma Entity Recommends 350% Dividend For Fy22

Alongside results companies considering their financials are also making dividend announcements for existing and potential investors. This is because for dividends, prospective investors can buy into the stock until cum dividend date i.e. the last date to buy shares in order to be eligible for receiving dividend. This is usually one day before the ex-dividend date. The company on the ex-dividend date adjusts in stock price considering the dividend announced.

Mid cap pharma company that has announced 350% dividend

Pfizer is a mid-cap pharma entity that in its board meet held on May 20, 2022 announced and recommended a dividend. In the exchange filing the company said, "The Board of Directors have at its Meeting held today, i.e., May 20, 2022, recommended a dividend of Rs. 35/- per equity share of Rs. 10/- each {350%) for the financial year ended
March 31, 2022. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 23, 2022".

So, the dividend payment date shall be on or before September 23, 2022.

 

 

Pfizer's Q4fy22 financials

As per the filing, the company's total revenue took a hit both sequentially as well as YoY and was reported at Rs. 566.78 crore. Net profit though increased year-on-year from Rs. 100.55 crore in the same period last year to last at Rs. 125.79 crore. In the December quarter, net profit was at Rs. 143.91 crore.

Disclaimer

The company's financials do not paint a very sound picture and we are not recommending this stock as a buy considering just the dividend aspect. Infact it is just for informational purpose only.